Mutational signatures of ionizing radiation in second malignancies

Sam Behjati(University of Cambridge), Gunes Gundem(Wellcome Sanger Institute), David C. Wedge(Centre for Human Genetics), Nicola D. Roberts(Wellcome Sanger Institute), Patrick Tarpey(Wellcome Sanger Institute), Susanna L. Cooke(Wellcome Sanger Institute), Peter Van Loo(The Francis Crick Institute), Ludmil B. Alexandrov(Wellcome Sanger Institute), Manasa Ramakrishna(Wellcome Sanger Institute), Helen Davies(Wellcome Sanger Institute), Serena Nik‐Zainal(Wellcome Sanger Institute), Claire Hardy(Wellcome Sanger Institute), Calli Latimer(Wellcome Sanger Institute), Keiran Raine(Wellcome Sanger Institute), Lucy Stebbings(Wellcome Sanger Institute), Andy Menzies(Wellcome Sanger Institute), David Jones(Wellcome Sanger Institute), Rebecca Shepherd(Wellcome Sanger Institute), Adam P. Butler(Wellcome Sanger Institute), Jon W. Teague(Wellcome Sanger Institute), Mette Jorgensen(London Cancer), Bhavisha Khatri(Royal National Orthopaedic Hospital), Nischalan Pillay(Royal National Orthopaedic Hospital), Adam Shlien(Hospital for Sick Children), P. Andrew Futreal(The University of Texas MD Anderson Cancer Center), Christophe Badie(Public Health England), ICGC Prostate Group(University of East Anglia), Colin S. Cooper(University of East Anglia), Rosalind A. Eeles(Institute of Cancer Research), Douglas F. Easton(University of Liverpool), Christopher S. Foster(University of Liverpool), David E. Neal(University of East Anglia), Daniel S. Brewer(University of East Anglia), Freddie C. Hamdy(Queen Mary University of London), Yong‐Jie Lu(Queen Mary University of London), Andy G. Lynch(Cancer Research UK), Charlie E. Massi(Chinese University of Hong Kong), Chi‐Fai Ng(Chinese University of Hong Kong), Hayley C. Whitaker(Second Military Medical University), Yongwei Yu(Second Military Medical University), Hongwei Zhang(Institute of Cancer Research), Elizabeth Bancroft(Institute of Cancer Research), Daniel M. Berney(Institute of Cancer Research), Niedzica Camacho(Institute of Cancer Research), Cathy Corbishley(Institute of Cancer Research), Tokhir Dadaev(Institute of Cancer Research), Nening M. Dennis(Royal Marsden NHS Foundation Trust), Tim Dudderidge(Royal Marsden NHS Foundation Trust), Sandra E. Edwards(Royal Marsden NHS Foundation Trust), Cyril Fisher(University of East Anglia), Jilur Ghori(University of East Anglia), Vincent J. Gnanapragasam(University of East Anglia), Christopher Greenman(University of East Anglia), Steve Hawkins(Royal Marsden NHS Foundation Trust), Steven Hazell(Royal Marsden NHS Foundation Trust), Will Howat(Cancer Research UK), Katalin Karászi(Cancer Research UK), Jonathan Kay(Institute of Cancer Research), Zsofia Kote‐Jarai(Institute of Cancer Research), Bárbara Kremeyer(Royal Marsden NHS Foundation Trust), Pardeep Kumar(Royal Marsden NHS Foundation Trust), Adam Lambert(Institute of Cancer Research), Daniel Leongamornlert(Royal Marsden NHS Foundation Trust), Naomi Livni(Royal Marsden NHS Foundation Trust), Hayley J. Luxton(Institute of Cancer Research), Lucy Matthews(Institute of Cancer Research), Erik Mayer(Institute of Cancer Research), Susan Merson(Royal Marsden NHS Foundation Trust), David Nicol(Royal Marsden NHS Foundation Trust), Christopher Ogden(Royal Marsden NHS Foundation Trust), Sarah O’Meara(John Radcliffe Hospital), Gill Pelvender(Cambridge University Hospitals NHS Foundation Trust), Nimish Shah(Cancer Research UK), Simon Tavaré(Institute of Cancer Research), Sarah Thomas(Royal Marsden NHS Foundation Trust), Alan Thompson(Royal Marsden NHS Foundation Trust), Clare Verrill(Cancer Research UK), Anne Y. Warren(Cancer Research UK), Jorge Zamora(Wellcome Sanger Institute), Ultan McDermott(Tampere University), G. Steven Bova(Brigham and Women's Hospital), Andrea L. Richardson(Brigham and Women's Hospital), Adrienne M. Flanagan(Wellcome Sanger Institute), Michael R. Stratton(University of Cambridge), Peter J. Campbell(University of Cambridge)
Nature Communications
September 12, 2016
Cited by 278Open Access
Full Text

Abstract

Ionizing radiation is a potent carcinogen, inducing cancer through DNA damage. The signatures of mutations arising in human tissues following in vivo exposure to ionizing radiation have not been documented. Here, we searched for signatures of ionizing radiation in 12 radiation-associated second malignancies of different tumour types. Two signatures of somatic mutation characterize ionizing radiation exposure irrespective of tumour type. Compared with 319 radiation-naive tumours, radiation-associated tumours carry a median extra 201 deletions genome-wide, sized 1-100 base pairs often with microhomology at the junction. Unlike deletions of radiation-naive tumours, these show no variation in density across the genome or correlation with sequence context, replication timing or chromatin structure. Furthermore, we observe a significant increase in balanced inversions in radiation-associated tumours. Both small deletions and inversions generate driver mutations. Thus, ionizing radiation generates distinctive mutational signatures that explain its carcinogenic potential.


Related Papers

No related papers found

Powered by citation graph analysis